OPVEE

Growth

nalmefene hydrochloride

NDANASALSPRAYPriority Review
Approved
May 2023
Lifecycle
Growth
Competitive Pressure
0/100
Clinical Trials
1

Mechanism of Action

receptors.

Indications (1)

Clinical Trials (1)

NCT04107051N/ACompleted

Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence

Started Oct 2019
533 enrolled
Alcohol Dependence

Loss of Exclusivity

LOE Date
Aug 4, 2042
199 months away
Patent Expiry
Aug 4, 2042
Exclusivity Expiry
May 22, 2026

Patent Records (2)

Patent #ExpiryTypeUse Code
11458091
Jul 10, 2038
Product
U-3630
12290596
Aug 4, 2042
U-4182